The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line-Reference-Cited by-同舟云学术

The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line

Published:2014-12 Issue:12 Volume:26 Page:2621-2632
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Satram-Maharaj Tamara,Nyarko Jennifer N.K.,Kuski Kelly,Fehr Kelsey,Pennington Paul R.,Truitt Luke,Freywald Andrew,Lukong Kiven Erique,Anderson Deborah H.,Mousseau Darrell D.

Funder

Canadian Breast Cancer Foundation

Canada-Saskatchewan Western Economic Partnership Agreement

Publisher

Elsevier BV

Subject

Cell Biology

Reference46 articles.

1. Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival

2. Use of Antidepressant Medications and the Possible Association with Breast Cancer Risk

3. An indicator of cancer: downregulation of Monoamine Oxidase-A in multiple organs and species

4. Amine oxidase activities in rat breast cancer induced experimentally with 7,12-dimethylbenz(α)anthracene

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications;Frontiers in Bioscience-Landmark;2024-08-19

2. Unveiling the Intricacies of Monoamine Oxidase-A (MAO-A) Inhibition in Colorectal Cancer: Computational Systems Biology, Expression Patterns, and the Anticancer Therapeutic Potential;ACS Omega;2024-08-09

3. A second life for MAO inhibitors? From CNS diseases to anticancer therapy;European Journal of Medicinal Chemistry;2024-03

4. Unveiling the Molecular Landscape of FOXA1 Mutant Prostate Cancer: Insights and Prospects for Targeted Therapeutic Strategies;International Journal of Molecular Sciences;2023-10-31

5. Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells;BioMed Research International;2023-10-05